Welcome to
Nordic Society of Gynaecological Oncology
Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M) in Combination Therapy for Ovarian Cancer
-Study to be conducted at multiple sites across Europe through
European Network of Gynaecological Oncological Trial groups (ENGOT)
Registration for NSGO Virtual Annual Meeting 10-12 March 2021 is closed.
Already registered for NSGO Annual Meeting 2021 – how to acces the recorded sessions read more HERE
Thank you for an Excellent NSGO-CTU Investigator Meeting 26 - 27 November 2020
We are looking forward to welcome you this year in
Copenhagen, Denmark from 25-26 November to NSGO-CTU Biannual Investigator Meeting 2021
A warm welcome to our two new Deputy Medical Directors:
Kristina Lindemann (Radiumhospital, Oslo) &
Kristine Madsen (Rigshospitalet, Copenhagen)
SEE THE NEW RESULTS OF THE CERVIX BT PLANNING MRI SURVEY,
CLICK HERE
ENGOT-EN3 / NSGO-PALEO
study results presented
at ESMO 2020
Mansoor Raza Mirza, Medical Director of NSGO-CTU, presented very exciting results from the ENGOT-EN3/NSGO-PALEO trial at 2020 ESMO Virtual Congress 2020.
Pay your membership fee
To pay your membership fee, kindly click HERE.
Direct links
Membership fee: